Smoking Cessation and Nicotine De addiction Products Market: By Product Type Electronic Cigarette, and Non-nicotine Products ), By Distribution Channel, and Geography
Smoking Cessation and Nicotine De-addiction Products Market size was valued at US$ 9,015 million in 2023 and is poised to grow at a CAGR of 12.8% from 2024-2030. Smoking Cessation and Nicotine De-addiction Products Market Of late, several governments across the globe coming up with policy changes to curb the smoking habit among people, which is likely to prompt smokers to adopt alternatives to smoking such as nicotine-based products or E-cigarettes.
Moreover, several governments are launching innovative awareness campaigns through digital, electronic, and print media to sensitize the people regarding harmful effects of smoking. These government initiatives are expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For Instance, countries/regions like China, India, and GCC countries brought laws that mandate that tobacco product manufacturers place warning labels on the products and the same laws prohibit smoking in public areas, these are expected to create a market opportunity for the players. Players in the smoking cessation & nicotine de-addiction products market are focusing on introducing newer and innovative therapies like varenicline and Cytisine to garner a larger market revenue share in the global smoking cessation & nicotine de-addiction products market. Moreover, players entering into collaborations and partnerships to increase the product market reach in various geographies.
Study Period
2024-2030Base Year
2023CAGR
12.8%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The growing prevalence of smoking and its hazardous effects on the cardiac and respiratory system is driving the smokers to adopt an alternative to smoking like nicotine-based products and E-cigarettes, this is expected to create a huge growth opportunity for market players over the forecast period. Moreover, consumers have been exposed to numerous innovative products in different formulations, which are helping buyers to choose the appropriate product for consumption, this in turn aiding the product adoption in the market. Moreover, regulatory approvals for Nicotine Replacement Therapies (NRT), non-nicotine based products and e-cigarettes are aiding the market revenue growth.
North America market is expected to hold the larger revenue share in global smoking cessation & nicotine de-addiction products market and projected to remain dominant over the forecast period owing to growing awareness and wider adoption choices in the region. Asia-pacific Smoking cessation & nicotine de-addiction products market projected to grow at highest CAGR over the forecast period in comparison with other regions owing to large smoking population and growing interest of multinational players in the region for geographic expansion.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
Report Study Period |
2024-2030 |
|
Market Size in 2023 |
US$ 9,015 million |
|
Market CAGR |
12.8% |
|
By Product Type |
|
|
By Distribution Channel |
|
|
By Region |
|
Download Free Sample Report
The smoking cessation and nicotine de-addiction products market size was valued at US$ 9,015 million in 2023
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
Cipla Ltd. (India) GlaxoSmithKline plc. (UK) ITC Limited (India) Johnson & Johnson Services Inc. (U.S) NJOY, Inc. (U.S) Novartis AG (Switzerland) Pfizer, Inc. (U.S) Takeda Pharmaceuticals Co. Ltd. (Japan)
| 1.Executive Summary |
| 2.Global Smoking Cessation and Nicotine De-Addiction Products Market Introduction |
| 2.1.Global Smoking Cessation and Nicotine De-Addiction Products Market - Taxonomy |
| 2.2.Global Smoking Cessation and Nicotine De-Addiction Products Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Distribution Channel |
| 2.2.3.Region |
| 3.Global Smoking Cessation and Nicotine De-Addiction Products Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Smoking Cessation and Nicotine De-Addiction Products Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Smoking Cessation and Nicotine De-Addiction Products Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Nicotine Based Products |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Electronic Cigarette |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Non-nicotine Products |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Global Smoking Cessation and Nicotine De-Addiction Products Market By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Hospital Pharmacies |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Retail Pharmacies |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Online Pharmacies |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Retail Stores |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Smoking Cessation and Nicotine De-Addiction Products Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. North America |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Europe |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Asia Pacific (APAC) |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Middle East and Africa (MEA) |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. Latin America |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 8.North America Smoking Cessation and Nicotine De-Addiction Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.1.1.Nicotine Based Products |
| 8.1.2.Electronic Cigarette |
| 8.1.3.Non-nicotine Products |
| 8.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.2.1.Hospital Pharmacies |
| 8.2.2.Retail Pharmacies |
| 8.2.3.Online Pharmacies |
| 8.2.4.Retail Stores |
| 8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 8.3.1.United States of America (USA) |
| 8.3.2.Canada |
| 9.Europe Smoking Cessation and Nicotine De-Addiction Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Nicotine Based Products |
| 9.1.2.Electronic Cigarette |
| 9.1.3.Non-nicotine Products |
| 9.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Hospital Pharmacies |
| 9.2.2.Retail Pharmacies |
| 9.2.3.Online Pharmacies |
| 9.2.4.Retail Stores |
| 9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Germany |
| 9.3.2.France |
| 9.3.3.Italy |
| 9.3.4.United Kingdom (UK) |
| 9.3.5.Spain |
| 9.3.6.Rest of EU |
| 10.Asia Pacific (APAC) Smoking Cessation and Nicotine De-Addiction Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Nicotine Based Products |
| 10.1.2.Electronic Cigarette |
| 10.1.3.Non-nicotine Products |
| 10.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Hospital Pharmacies |
| 10.2.2.Retail Pharmacies |
| 10.2.3.Online Pharmacies |
| 10.2.4.Retail Stores |
| 10.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.China |
| 10.3.2.India |
| 10.3.3.Australia and New Zealand (ANZ) |
| 10.3.4.Japan |
| 10.3.5.Rest of APAC |
| 11.Middle East and Africa (MEA) Smoking Cessation and Nicotine De-Addiction Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Nicotine Based Products |
| 11.1.2.Electronic Cigarette |
| 11.1.3.Non-nicotine Products |
| 11.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Hospital Pharmacies |
| 11.2.2.Retail Pharmacies |
| 11.2.3.Online Pharmacies |
| 11.2.4.Retail Stores |
| 11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.GCC Countries |
| 11.3.2.South Africa |
| 11.3.3.Rest of MEA |
| 12.Latin America Smoking Cessation and Nicotine De-Addiction Products Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Nicotine Based Products |
| 12.1.2.Electronic Cigarette |
| 12.1.3.Non-nicotine Products |
| 12.2. Distribution Channel Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Hospital Pharmacies |
| 12.2.2.Retail Pharmacies |
| 12.2.3.Online Pharmacies |
| 12.2.4.Retail Stores |
| 12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Brazil |
| 12.3.2.Mexico |
| 12.3.3.Rest of LA |
| 13. Competition Landscape |
| 13.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 13.2.1.Cipla Ltd. (India) |
| 13.2.2.GlaxoSmithKline plc. (UK) |
| 13.2.3.ITC Limited (India) |
| 13.2.4.Johnson & Johnson Services Inc. (U.S) |
| 13.2.5.NJOY, Inc. (U.S) |
| 13.2.6.Novartis AG (Switzerland) |
| 13.2.7.Pfizer, Inc. (U.S) |
| 13.2.8.Takeda Pharmaceuticals Co. Ltd. (Japan) |
| 13.2.9.VMR products, LLC (U.S) |
| 14. Research Methodology |
| 15. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.
Download Free Sample
